FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4303613813> ?p ?o ?g. }

• W4303613813 endingPage "4847" @default.
• W4303613813 startingPage "4847" @default.
• W4303613813 abstract "Immunotherapy modulating the tumor microenvironment (TME) immune function has a promising effect on various types of cancers, but it remains as a limited efficacy in colon cancer. Midostaurin (PKC412) has been used in the clinical treatment of fms-like tyrosine kinase 3 (FLT3)-mutant acute myeloid leukemia and has demonstrated immunomodulatory activity. We aimed to evaluate the effect of midostaurin on the modulation of TME and the efficacy of anti-programmed cell death protein 1 (PD-1) against colon cancer. Midostaurin inhibited the growth of murine CT26 and human HCT116 and SW480 cells with multinucleation and micronuclei formation in morphology examination. The cell cycle arrested in the G2/M phase and the formation of the polyploid phase was noted. The formation of cytosolic DNA, including double-strand and single-strand DNA, was increased. Midostaurin increased mRNA expressions of cGAS, IRF3, and IFNAR1 in colorectal adenocarcinoma cells and mouse spleen macrophages. The protein expressions of Trex-1, c-KIT, and Flt3, but not PKCα/β/γ and VEGFR1, were down-regulated in midostaurin-treated colorectal adenocarcinoma cells and macrophages. Trex-1 protein expression was abrogated after FLT3L activation. In vivo, the combination of midostaurin and anti-PD-1 exhibited the greatest growth inhibition on a CT26-implanted tumor without major toxicity. TME analysis demonstrated that midostaurin alone decreased Treg cells and increased neutrophils and inflammatory monocytes. NKG2D+ and PD-1 were suppressed and M1 macrophage was increased after combination therapy. When combined with anti-PD-1, STING and INFβ protein expression was elevated in the tumor. The oral administration of midostaurin may have the potential to enhance anti-PD-1 efficacy, accompanied by the modulation of cytosolic DNA-sensing signaling and tumor microenvironment." @default.
• W4303613813 created "2022-10-08" @default.
• W4303613813 creator A5044776215 @default.
• W4303613813 creator A5052538119 @default.
• W4303613813 creator A5064655192 @default.
• W4303613813 creator A5069103876 @default.
• W4303613813 creator A5071126579 @default.
• W4303613813 creator A5091086932 @default.
• W4303613813 date "2022-10-04" @default.
• W4303613813 modified "2023-10-01" @default.
• W4303613813 title "Midostaurin Modulates Tumor Microenvironment and Enhances Efficacy of Anti-PD-1 against Colon Cancer" @default.
• W4303613813 cites W1585383225 @default.
• W4303613813 cites W1964261536 @default.
• W4303613813 cites W1977315768 @default.
• W4303613813 cites W1990869196 @default.
• W4303613813 cites W1993860509 @default.
• W4303613813 cites W1998548135 @default.
• W4303613813 cites W1999611522 @default.
• W4303613813 cites W2004585452 @default.
• W4303613813 cites W2021759592 @default.
• W4303613813 cites W2035252444 @default.
• W4303613813 cites W2047365750 @default.
• W4303613813 cites W2054985451 @default.
• W4303613813 cites W2054995801 @default.
• W4303613813 cites W2055764602 @default.
• W4303613813 cites W2101653483 @default.
• W4303613813 cites W2112727687 @default.
• W4303613813 cites W2121288523 @default.
• W4303613813 cites W2129615499 @default.
• W4303613813 cites W2130921932 @default.
• W4303613813 cites W2138985803 @default.
• W4303613813 cites W2154171253 @default.
• W4303613813 cites W2154625299 @default.
• W4303613813 cites W2160008529 @default.
• W4303613813 cites W2167949866 @default.
• W4303613813 cites W2171232394 @default.
• W4303613813 cites W2220279767 @default.
• W4303613813 cites W2472403803 @default.
• W4303613813 cites W2518932857 @default.
• W4303613813 cites W2580868078 @default.
• W4303613813 cites W2615498501 @default.
• W4303613813 cites W2624275086 @default.
• W4303613813 cites W2736420338 @default.
• W4303613813 cites W2787221390 @default.
• W4303613813 cites W2793564579 @default.
• W4303613813 cites W2795875233 @default.
• W4303613813 cites W2888038493 @default.
• W4303613813 cites W2889646458 @default.
• W4303613813 cites W2902864530 @default.
• W4303613813 cites W2981285743 @default.
• W4303613813 cites W3039484069 @default.
• W4303613813 cites W3115597636 @default.
• W4303613813 cites W3176237514 @default.
• W4303613813 doi "https://doi.org/10.3390/cancers14194847" @default.
• W4303613813 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36230769" @default.
• W4303613813 hasPublicationYear "2022" @default.
• W4303613813 type Work @default.
• W4303613813 citedByCount "5" @default.
• W4303613813 countsByYear W43036138132022 @default.
• W4303613813 countsByYear W43036138132023 @default.
• W4303613813 crossrefType "journal-article" @default.
• W4303613813 hasAuthorship W4303613813A5044776215 @default.
• W4303613813 hasAuthorship W4303613813A5052538119 @default.
• W4303613813 hasAuthorship W4303613813A5064655192 @default.
• W4303613813 hasAuthorship W4303613813A5069103876 @default.
• W4303613813 hasAuthorship W4303613813A5071126579 @default.
• W4303613813 hasAuthorship W4303613813A5091086932 @default.
• W4303613813 hasBestOaLocation W43036138131 @default.
• W4303613813 hasConcept C203014093 @default.
• W4303613813 hasConcept C2776107976 @default.
• W4303613813 hasConcept C2776481607 @default.
• W4303613813 hasConcept C2777701055 @default.
• W4303613813 hasConcept C2778729363 @default.
• W4303613813 hasConcept C3020616263 @default.
• W4303613813 hasConcept C502942594 @default.
• W4303613813 hasConcept C71924100 @default.
• W4303613813 hasConcept C86803240 @default.
• W4303613813 hasConcept C8891405 @default.
• W4303613813 hasConceptScore W4303613813C203014093 @default.
• W4303613813 hasConceptScore W4303613813C2776107976 @default.
• W4303613813 hasConceptScore W4303613813C2776481607 @default.
• W4303613813 hasConceptScore W4303613813C2777701055 @default.
• W4303613813 hasConceptScore W4303613813C2778729363 @default.
• W4303613813 hasConceptScore W4303613813C3020616263 @default.
• W4303613813 hasConceptScore W4303613813C502942594 @default.
• W4303613813 hasConceptScore W4303613813C71924100 @default.
• W4303613813 hasConceptScore W4303613813C86803240 @default.
• W4303613813 hasConceptScore W4303613813C8891405 @default.
• W4303613813 hasFunder F4320322795 @default.
• W4303613813 hasFunder F4320322950 @default.
• W4303613813 hasIssue "19" @default.
• W4303613813 hasLocation W43036138131 @default.
• W4303613813 hasLocation W43036138132 @default.
• W4303613813 hasLocation W43036138133 @default.
• W4303613813 hasLocation W43036138134 @default.
• W4303613813 hasOpenAccess W4303613813 @default.
• W4303613813 hasPrimaryLocation W43036138131 @default.
• W4303613813 hasRelatedWork W2074869009 @default.

• next